Unlike the continuum offered by transcriptomic analysis, IHC allowed to identify expression of TfR at significantly higher levels than background in 62/99 (62.6%) of breast cancer versus 2/8 (25%) of control breast tissue. Here, TFRC is linked to breast carcinoma.